Merck
CN
Search Within
文件类型

108-16-7

应用筛选条件
关键词:'108-16-7'
显示 1-30 共 359 条结果 关于 "108-16-7" 范围 技术文档
Quality Control Ranges: Milliplex Human High Sensitivity T Cell Magnetic Bead Panel
IL-10 Control 1 52 – 108 pg/mL IL-6 Control 1 5.7 – 12 pg/mL Control 2 254 – 527 pg/mL Control 2 29 – 59 pg/mL
The Effective Use of Protein Kinase Inhibitors
104 14 1 7 60 87 1 101 97 68 120 93 80 66 100 90 79 102 76 85 80 95 109 107 122 18 6 7 0 104 103 27 52 41 97 99 82 94 62
Verfication summary-03-0202-00
HMN108012 3 MRD (1:2) 57.71 7.9 14% 115.42 7.9 7% - 3 1:4 29.56 1.5 5% 118.24 1.5 1% 102% 3 1:8 15.55 1.0 6% 124.38 1.0 1% 108% 3 1:16 8.14 0.6 7% 130.23 0.6 0% 113%
Verfication summary-03-0202-00
HMN108012 3 MRD (1:2) 57.71 7.9 14% 115.42 7.9 7% - 3 1:4 29.56 1.5 5% 118.24 1.5 1% 102% 3 1:8 15.55 1.0 6% 124.38 1.0 1% 108% 3 1:16 8.14 0.6 7% 130.23 0.6 0% 113%
Data Sheet - C8406
water bath. 6. Prepare a suspension of 5 x 108 cells/ml of antibody sensitized sheep erythrocytes, EA7S, (Product No. E9383) in ice cold GVB2+. 7. Pipette 400 µl of the antibody sensitized sheep
Data Sheet - C8567 - Lot 083H9480
Prepare a suspension of 1.5 x 108 cells/ml of antibody sensitized sheep erythrocytes (Product No. E9383, EA7S) in GVB2+. 6. Prepare reaction tubes according to Table 1. 7. Incubate all tubes in a 37EC
Product Information Sheet-LYSISO1
cultured cells (~3 × 108 cells) • Perform the whole procedure at 2-8 °C. • All the solutions and equipment should be pre-cooled before use. • Homogenize the samples using a 7
LABORATORY NOTEBOOK ISSUANCE PAGE
0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015 0.19 90 7 540 8 200 0.006 0.16 85
Lab Notebook Guidelines
0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015 0.19 90 7 540 8 200 0.006 0.16 85
Validation and Qualification for Durapore® Sterilizing-Grade (0.22 µm) Membrane VMF4
8.29 115 6 12.8 6.50 104 16 16.0 >8.29 98 41 12.8 6.50 104 17 15.9 >8.29 98 52 12.6 6.50 108 18 15.6 >8.29 92 23 12.6 6.53 106 28 14.1 >8.36
LABORATORY NOTEBOOK ISSUANCE PAGE
0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015 0.19 90 7 540 8 200 0.006 0.16 85
LABORATORY NOTEBOOK ISSUANCE PAGE
0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015 0.19 90 7 540 8 200 0.006 0.16 85
QCM™ Endothelial Cell Migration Assay
CD 0 1.0×107 2.0×107 3.0×107 4.0×107 5.0×107 6.0×107 7.0×107 8.0×107 9.0×107 1.0×108 1.1×108 1.2×108 1.3×108 1.4×108 BSA FBS BSA+Lat FBS+Lat BSA+CD FBS+CD Fl uo re sc en ce in te ns
Data Sheet - 83913
β-mercaptoethanol to 14ml of denaturating solution per 108 cells. This solution can be stored one month at room temperature. 2. Add 10ml of solution D per 108 cells. Mix thoroughly and allow to sit 1 min at
Data Sheet - C8567 - Lot 049H9276
C1q with GVB2+. 6. Prepare a suspension of 1.5 x 108 cells/ml of antibody sensitized sheep erythrocytes (Product No. E9383, EA7S) in GVB2+. 7. Prepare reaction tubes on ice according to Table 1.
TB029
1 2130 Sau96I 14 Sau3AI 24 ScaI 1 3619 ScrFI 14 SfaNI 19 SfcI 4 108 2511 2702 3380 SgrAI 1 181 SphI 1 337 SspI 1 3943 StyI 1 1140 TaqI 7 137 145 423 898 1039 2346 3790 TaqII 6 441 2148 3487 3672 3825
Product Information Sheet - RPROTKRO
mammalian cells • 25–50 mg mammalian tissue • 0.2–0.5 cm (25–50 mg) mouse tail • 109 bacteria or 108 yeast cells • 25–50 mg formalin-fixed paraffin-embedded tissue section 0519.03368548001➆ Add 40
The Effective Use of Protein Kinase Inhibitors
104 14 1 7 60 87 1 101 97 68 120 93 80 66 100 90 79 102 76 85 80 95 109 107 122 18 6 7 0 104 103 27 52 41 97 99 82 94 62
Data Sheet - C8406 - Lot 010K4044
bath. 6. Prepare a suspension of 5 x 108 cells/ml of antibody sensitized sheep erythrocytes (Sigma Product No. E7509, EA7S) in ice cold GVB2+. 7.
Product Information Sheet - PEROX1
From Cell Cultures (~2 × 108 cells) Perform the procedure at 4 °C. All solutions and equipment should be cooled before use. Homogenize the samples using a 7 mL Dounce glass tissue grinder
Product Information Sheet - E6888
co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. Thromb. Res., 108(1), 77-84 (2002). 8. Volpini, R. A., et al., Effect of enalapril and losartan on the events that
N-TER/siRNA nanoparticle mediated knockdown of gene expression
NFSdilute 108 108 288 288 432 432 720 720 1260 1260 NFS 9 18 25 51 35 71 66 133 166 332 0.5´ N-TER Buffer 99 90 263 237 397 361 654 587 1094 928 Serum-free
Millicell® Hanging Cell Culture Inserts
00120354, Rev. A, 11/14 Specifications Insert Dimensions 24-well 12-well 6-well Height 16 mm 16 mm 16 mm Outer diameter 9 mm 15 mm 27 mm Inner diameter 6.5 mm 12 mm 24 mm Membrane area (
Data Sheet - G5540
, et al., Cell, 87, 1327-1338 (1996). 7. McHugh, T. J., et al., Cell, 87, 1339-1349 (1996). 8. Advokat, C. and Pellegrin, A. I., Neurosci. Biobehav. Rev., 16, 13-24 (1992). 9. Beal, M. F., FASEB
Data Sheet - G5665
, et al., Cell, 87, 1327-1338 (1996). 7. McHugh, T. J., et al., Cell, 87, 1339-1349 (1996). 8. Advokat, C. and Pellegrin, A. I., Neurosci. Biobehav. Rev., 16, 13-24 (1992). 9. Beal, M. F., FASEB
Quality Control Range Sheet- HSTC-108 and HSTC-208
Catalog# MHSTCMAG-70K, MHSTCMAG-70KPMX, and MHSTCMAG-70KPXBK Control Catalog # MHSTC-6070, Lot # HSTC-108 and HSTC-208 MHSTC-6070: HSTC-108.208 (01 February 2024) EMD MILLIPORE • 1-800-645-5476 • 1
Data Sheet - L6787
-arginine N7778 7-Nitroindazole O0886 Olomoucine O3636 ODQ P-106 3-Phenylpropargylamine hydrochloride P-215 PD 098,059 P3510 Papaverine hydrochloride R-106 Ro 16-6491 hydrochloride
Data Sheet - B7150 - Lot 061K88041
100 110 120 130 140 150 160 0 5000 15000 m/z Abundance 41 52 65 74 81 92 108 120 137 150 165 10000 Hewlett-Packard 5890
Product Information - L6787
-arginine N7778 7-Nitroindazole O0886 Olomoucine O3636 ODQ P-106 3-Phenylpropargylamine hydrochloride P-215 PD 098,059 P3510 Papaverine hydrochloride R-106 Ro 16-6491 hydrochloride
Data Sheet - G5790
, et al., Cell, 87, 1327-1338 (1996). 7. McHugh, T. J., et al., Cell, 87, 1339-1349 (1996). 8. Advokat, C. and Pellegrin, A. I., Neurosci. Biobehav. Rev., 16, 13-24 (1992). 9. Beal, M. F., FASEB
1/12